| Literature DB >> 29524037 |
A Grebinyk1,2, S Prylutska3, I Grynyuk4, B Kolp2, V Hurmach1, T Sliva4, V Amirkhanov4, V Trush4, O Matyshevska1, M Slobodyanik4, Yu Prylutskyy1, M Frohme2, U Ritter5.
Abstract
New representative of carbacylamidophosphates - diphenyl-N-(trichloroacetyl)-amidophosphate (HL), which contains two phenoxy substituents near the phosphoryl group, was synthesized, identified by elemental analysis and IR and NMR spectroscopy, and tested as a cytotoxic agent itself and in combination with C60 fullerene.According to molecular simulation results, C60 fullerene and HL could interact with DNA and form a rigid complex stabilized by stacking interactions of HL phenyl groups with C60 fullerene and DNA G nucleotide, as well as by interactions of HL CCl3 group by ion-π bonds with C60 molecule and by electrostatic bonds with DNA G nucleotide.With the use of MTT test, the cytotoxic activity of HL against human leukemic CCRF-CM cells with IC50 value detected at 10 μM concentration at 72 h of cells treatment was shown. Under combined action of 16 μM C60 fullerene and HL, the value of IC50 was detected at lower 5 μM HL concentration and at earlier 48 h period of incubation, besides the cytotoxic effect of HL was observed at a low 2.5 μM concentration at which HL by itself had no influence on cell viability. Binding of C60 fullerene and HL with minor DNA groove with formation of a stable complex is assumed to be one of the possible reasons of their synergistic inhibition of CCRF-CЕM cells proliferation.Application of C60 fullerene in combination with 2.5 μM HL was shown to have no harmful effect on structural stability of blood erythrocytes membrane. Thus, combined action of C60 fullerene and HL in a low concentration potentiated HL cytotoxic effect against human leukemic cells and was not followed by hemolytic effect.Entities:
Keywords: C60 fullerene; DNA; Diphenyl-N-(trichloroacetyl)-amidophosphate (HL); Leukemic CCRF-CEM cells; Molecular simulation
Year: 2018 PMID: 29524037 PMCID: PMC5845026 DOI: 10.1186/s11671-018-2490-9
Source DB: PubMed Journal: Nanoscale Res Lett ISSN: 1556-276X Impact factor: 4.703
Fig. 1The structure of diphenyl-N-(trichloroacetyl)-amidophosphate (HL)
Fig. 2Scheme of solubility of diphenyl-N-(trichloroacetyl)-amidophosphate (HL) in sodium salt
Fig. 3Interaction of diphenyl-N-(trichloroacetyl)-amidophosphate (HL) with DNA molecule: a, b binding with minor and major grooves; c intercalation into a minor groove. The used DNA structure from PDB database: a, b—2M2C and c—1XRW
Energy parameters (kJ/mol) of diphenyl-N-(trichloroacetyl)-amidophosphate (HL) interaction alone and in combination with C60 fullerene with DNA double-helix
| Structure | The energy parameters | ||||
|---|---|---|---|---|---|
| FreE | Cntc | Hbnd | Bump | Int | |
| Binding with a major DNA groove | |||||
| HL | − 6.6 | − 45.1 | − 2.0 | 2.5 | 6.3 |
| HL+С60 | − 23.1 | − 75.7 | − 2.3 | 8.8 | 5.0 |
| Binding with a minor DNA groove | |||||
| HL | − 13.1 | − 56.8 | − 1.8 | 2.5 | 3.6 |
| HL+С60 | − 23.3 | − 84.7 | 0.0 | 7.8 | 6.8 |
| Intercalation into a minor DNA groove | |||||
| HL | − 8.0 | − 62.2 | − 1.0 | 6.2 | 8.7 |
| HL+С60 | − 8.0 | − 62.2 | − 1.0 | 6.2 | 8.7 |
| С60+HL | − 23.5 | − 100 | 0.0 | 20.0 | 5.2 |
FreE the total energy of compounds binding with DNA; Cntc the contact energy of compounds interaction with DNA; Hbnd the energy of hydrogen bonds; Bump the energy of steric clashes between DNA and build-in compounds; Int the energy of steric clashes between the atoms of build-in compounds
Fig. 4Combined interaction of diphenyl-N-(trichloroacetyl)-amidophosphate (HL) and C60 fullerene with DNA (HL+C60 or C60+HL versions): a, b binding with minor and major grooves, c, d intercalation into minor and major grooves. The used DNA structures of the PDB database: a, b—2M2C, c—1XRW, and d—2MIW
Fig. 5Viability of CCRF-CEM cells incubated with diphenyl-N-(trichloroacetyl)-amidophosphate (HL) in different concentrations. (M ± m, n = 8); *p < 0.05 compared to control cells
Fig. 6Viability of CCRF-CEM cells incubated with diphenyl-N-(trichloroacetyl)-amidophosphate (HL) alone or in combination with 16 μM C60 fullerene. (M ± m, n = 8); *p < 0.05 compared to control cells; #p < 0.05 compared to HL
Fig. 7Erythrocytes resistance to hemolysis in the presence of diphenyl-N-(trichloroacetyl)-amidophosphate (HL) separately and in combination with 16 μM C60 fullerene. (M ± m, n = 8)